| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/03/2010 | EP2149567A1 Cyclic polyamines for binding phosphatidylserine |
| 02/03/2010 | EP2148886A1 Tubulysine derivatives |
| 02/02/2010 | US7655752 TNF-α converting enzyme inhibitory agents and method of using same |
| 02/02/2010 | US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 02/02/2010 | US7655643 (8S,11S,14S)-14-Amino-11-(3-aminopropyl)-5-fluoro -17-hydroxy-10,13-dioxo-9,12-diazatricyclo[14.3.1.12,6]henicosa-1(20),2(21),3,5,16,18-hexaene-8-carboxylic acid dihydrochloride; antibacterial activity on S. aureus strains which are resistant to biphenomycin |
| 02/02/2010 | US7655472 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2196286C Parallel selex |
| 01/28/2010 | WO2010011566A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 01/28/2010 | WO2009136752A9 Novel peptide for augmenting brain-derived neutrotrophic factor (bdnf) protein expression in hippocampal neurons, hippocampal tissue and cerebral-cortex tissue |
| 01/28/2010 | WO2004005463A9 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| 01/28/2010 | US20100022748 Prophylactic agent for renal failure |
| 01/28/2010 | US20100022747 Prophylactic agent for heart failure |
| 01/28/2010 | US20100021939 Process for detecting enzyme activity in an immunoassay |
| 01/28/2010 | US20100021510 Neuronal exocytosis inhibiting peptides |
| 01/28/2010 | CA2731177A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 01/27/2010 | EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof |
| 01/27/2010 | EP1489125B1 Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicines |
| 01/27/2010 | CN101636407A Bis-sulfhydryl macrocyclization systems |
| 01/27/2010 | CN101633688A Leucine dipeptide analog, preparation method and application thereof |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/26/2010 | US7652153 Caspase inhibitors and uses thereof |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652025 Remedies for sepsis |
| 01/26/2010 | US7651997 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/26/2010 | CA2188817C Angiogenesis inhibitor |
| 01/21/2010 | WO2010009196A1 Synthesis of bis-peptides oligomers comprising at least one n-substituted diketopiperazine as structural moiety |
| 01/21/2010 | WO2010007250A1 D,d-muramyl dipeptides, derived compounds and use thereof for the treatment of atheromatous plaques |
| 01/21/2010 | WO2010006755A2 A compound for imaging cell death |
| 01/21/2010 | WO2008115809A3 Cytokines and genes differentially affected by tnf blockers |
| 01/21/2010 | WO2004039333A9 ANTIGENIC gp 100 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 01/21/2010 | US20100016550 Methods for Site-Specific Pegylation |
| 01/21/2010 | US20100016549 Peyer's patch and/or m-cell targeting ligands |
| 01/21/2010 | US20100016243 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 01/21/2010 | US20100016166 Plant Growth Regulator and use Thereof |
| 01/21/2010 | US20100015197 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 01/21/2010 | US20100015092 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/21/2010 | US20100015070 Use of natural, recombinant and synthetic resilins in cosmetics |
| 01/21/2010 | US20100015058 Radiolabeled bbn-rgd heterodimers for cancer targeting |
| 01/21/2010 | CA2731053A1 A compound for imaging cell death |
| 01/20/2010 | EP2145630A2 Angiotensin-converting enzyme inhibitory peptides |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | CA2551157C Novel kappa receptor selective opioid peptides |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/18/2010 | CA2689686A1 Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof |
| 01/14/2010 | WO2010003231A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | WO2002072609A9 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 01/14/2010 | US20100009965 Cyclic malonamides as inhibitors of abeta protein production |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | CA2727574A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/13/2010 | EP2143786A1 Method for producing dipeptide |
| 01/13/2010 | EP2143727A1 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 01/13/2010 | EP2142649A2 Breast cancer methods, medicaments and agents |
| 01/13/2010 | CN101627049A Synthetic peptide amides |
| 01/13/2010 | CN101624417A Specific inhibitor for toxic protein granzyme M of human immune system, preparation method and application |
| 01/12/2010 | US7645805 a core which is functionalized with three amino acid derived groups by means of an amide or urea linkage. It may be used to gelate or thicken numerous solvents |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010002042A1 Enzyme substrate for labeling of protein |
| 01/07/2010 | WO2009135015A3 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
| 01/07/2010 | WO2009108713A3 Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides |
| 01/07/2010 | US20100004180 Agents for the Detection and Modulation of B-Cells and Antibodies |
| 01/07/2010 | US20100004179 Targeting of ews-fli1 as anti-tumor therapy |
| 01/07/2010 | US20100004175 Novel bmp-12-related proteins and methods of their manufacture |
| 01/07/2010 | US20100003305 Biocompatible and biodegradable elastomeric polymers |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | DE102008032828A1 Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel Tryptophan-containing peptides from alpha-lactalbumin with antihypertensive and vasoprotective effect for biofunctional food |
| 01/06/2010 | EP2140875A1 Compositions and methods for healthy pregnancy |
| 01/06/2010 | EP2139910A2 Method for the synthesis of peptides without solvent |
| 01/06/2010 | EP2139337A1 Inhibitors of fibroblast activation protein, and methods of use thereof |
| 01/06/2010 | EP1885364B1 Halogenated quindoline dimers for the treatment of cancer |
| 01/06/2010 | EP1697401B1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 01/06/2010 | EP1427713B1 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 01/06/2010 | CN100577652C Method for synthesizing esters of N-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642245 bactericide for treating drug resistant bacteria |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |
| 01/05/2010 | US7642045 Antibodies to protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells |
| 01/05/2010 | US7642044 Trimerising module |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | CA2184681C Process for preparing substituted n-ethylglycine derivatives |
| 12/31/2009 | US20090326194 Process for preparing macrocyclic compounds |
| 12/31/2009 | US20090325889 Hepatitis c serine protease inhibitors and uses therefor |
| 12/31/2009 | US20090325888 Peptides having a health benefit and compositions comprising them |
| 12/31/2009 | US20090325887 Peptides and regulation of calcium channels |
| 12/31/2009 | US20090324621 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 12/31/2009 | US20090324499 Vitamin-targeted imaging agents |
| 12/30/2009 | WO2009156687A2 New streptomyces barakatei strain, culture filtrate, derived active compounds and use thereof in the treatment of plants |
| 12/30/2009 | WO2009155709A1 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 12/30/2009 | WO2009018477A3 Methods of inhibiting calcineurin with apoe analogs |
| 12/30/2009 | EP2138506A2 Synthesis of N-N-(3,3-dimethylbutyl)-L-alpha-aspartyl-L-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors |
| 12/30/2009 | EP1618380B1 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
| 12/30/2009 | CN101613307A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 12/30/2009 | CA2728933A1 Bridged secondary amines and use thereof as iap bir domain binding compounds |